Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study

John Moore, Nada Hamad, David Gottlieb, Ashish Bajel, David Ritchie, David Yeung, Matthew Greenwood, Duncan Purtill, Steven Tran, Annie Solterbeck, Donna Aarons, John Kwan

Blood Adv (2023) 7 (18): 5554–5565.

https://doi.org/10.1182/bloodadvances.2023009840

Published: 2023

Includes: Supplemental data